
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.920 | 0.920 | 0.000 |
Shares | 99.080 | 99.080 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 11.970 | 17.726 |
Price to Book | 1.955 | 2.484 |
Price to Sales | 0.948 | 2.003 |
Price to Cash Flow | 6.021 | 10.035 |
Dividend Yield | 2.392 | 2.663 |
5 Years Earnings Growth | 12.821 | 10.808 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 30.990 | 10.696 |
Communication Services | 19.160 | 9.839 |
Energy | 18.160 | 2.751 |
Financial Services | 13.200 | 14.237 |
Technology | 6.760 | 23.602 |
Consumer Defensive | 5.890 | 10.599 |
Industrials | 5.820 | 13.559 |
Number of long holdings: 17
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex Pharmaceuticals Inc | - | 7.21 | - | - | |
Vodafone Group PLC ADR | - | 6.75 | - | - | |
Telefonaktiebolaget L M Ericsson ADR Class B | - | 6.70 | - | - | |
XP Inc Class A | - | 6.54 | - | - | |
Bank Bradesco SA ADR | - | 6.54 | - | - | |
Telefonica SA ADR | - | 6.34 | - | - | |
Sanofi SA ADR | - | 6.17 | - | - | |
Halliburton Co | - | 6.15 | - | - | |
Shell PLC ADR Class A | - | 6.05 | - | - | |
Merck & Co Inc | - | 6.04 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
COMPASS INVESTMENTS DIECIOCHO B-E2 | 873.78M | 2.38 | 12.32 | - | ||
COMPASS INVESTMENTS DIECIOCHO A | 873.78M | 2.35 | 12.31 | - | ||
Compass Investments Cinco SIRV B E1 | 634.18M | -2.46 | 9.20 | 7.54 | ||
Compass Investments Cinco A | 634.18M | -1.16 | 12.15 | 9.05 | ||
Compass Investments Cinco B-EG1 | 634.18M | -2.18 | 9.83 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review